HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The sealing of vascular prostheses using autologous electrically activated blood.

Abstract
Due to preclotting of the vascular prosthesis, autologous blood has shown good results provided that heparinization has not become necessary, or blood coagulation disorders are not present. In cases where replacement of the aorta is performed in the thoracic cavity with extracorporeal circulation or in the case of severe coagulopathies, preclotting with autologous blood does not show satisfactory results. In this presentation we report on a new method of sealing vascular prostheses with the help of autologous blood activated electrically "in vitro". The direct current changes the blood in vitro into a thrombogenic substance. Sealing is effected by placing the outer wall of the prosthesis in electrically activated blood.
AuthorsK M Sedlarik, W Ursinus, C Lichey, A Reichert, B Schilling
JournalThe Thoracic and cardiovascular surgeon (Thorac Cardiovasc Surg) Vol. 32 Issue 5 Pg. 329-30 (Oct 1984) ISSN: 0171-6425 [Print] Germany
PMID6083627 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Aortic Aneurysm (surgery)
  • Aortic Valve Insufficiency (surgery)
  • Blood Coagulation
  • Blood Vessel Prosthesis
  • Electric Conductivity
  • Heart Valve Prosthesis
  • Hemorrhage (prevention & control)
  • Humans
  • Male
  • Postoperative Complications (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: